CAI
Caris Life Sciences, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #948
- Final score
- 15.17
- Years on list
- 1
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 23 since 2024
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | CAI | MDGL | VKTX |
|---|---|---|---|
| Climate Change | 12.1 | 15.8 | 17.8 |
| Employee Relations | 17.0 | 18.0 | 18.0 |
| Environment | 10.8 | 7.5 | 6.4 |
| Stakeholders & Society | 21.0 | 19.5 | 18.0 |
| Human Rights | 4.7 | 22.2 | 4.7 |
| Governance | 14.2 | 29.7 | 17.1 |
| Performance Rating | 50.0 | 38.3 | 37.4 |